MetaCap

Janux Therapeutics Statistics

NASDAQ: JANXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

10.08-0.21 (-2.04%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Janux Therapeutics by the numbers

Janux Therapeutics has a market capitalization of $616.7 million based on 61.18M shares outstanding. With trailing EPS of $-1.59, Janux Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 36.8% below its 50-day average and 34.1% below its 200-day average.

Average daily trading volume is 961.56K shares, or about $9.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

JANX valuation vs. peer median

JANX compared with the median of 8 peer companies
MetricJANXPeer medianDifference
Market cap$616.73M$615.62M+0%
Avg. volume961.56K1.36M-29%

Peer median across 8 companies: ABUS, OLMA, KURA, ANNX, SGMT, IMMX, DSGN, NVCT.

Valuation

Market cap
$616.73M
Price / sales (latest FY)
61.67
EPS (TTM)
$-1.59

Price and trading

Previous close
10.29
Open
10.16
Day range
10.05 – 10.54
52-week range
10.05 – 35.34
52-week change
-65.00%
Beta
—
Volume
1.11M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
616.73M
Forward Pe
-3.95
Eps
-1.59
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
35.34
Week52 Low
10.05
Avg Volume
961.56K
Shares Outstanding
61.18M
Ma50
15.96
Ma200
15.28
Earnings Date
Nov 5, 2026
Pct From52w High
-71.48%
Pct From52w Low
0.30%

Related